1. Home
  2. FBIO vs LPSN Comparison

FBIO vs LPSN Comparison

Compare FBIO & LPSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FBIO
  • LPSN
  • Stock Information
  • Founded
  • FBIO 2006
  • LPSN 1995
  • Country
  • FBIO United States
  • LPSN United States
  • Employees
  • FBIO N/A
  • LPSN 928
  • Industry
  • FBIO Biotechnology: Pharmaceutical Preparations
  • LPSN EDP Services
  • Sector
  • FBIO Health Care
  • LPSN Technology
  • Exchange
  • FBIO Nasdaq
  • LPSN Nasdaq
  • Market Cap
  • FBIO 88.7M
  • LPSN 93.7M
  • IPO Year
  • FBIO N/A
  • LPSN 2000
  • Fundamental
  • Price
  • FBIO $3.38
  • LPSN $0.96
  • Analyst Decision
  • FBIO Strong Buy
  • LPSN Hold
  • Analyst Count
  • FBIO 2
  • LPSN 1
  • Target Price
  • FBIO $16.50
  • LPSN N/A
  • AVG Volume (30 Days)
  • FBIO 1.1M
  • LPSN 2.5M
  • Earning Date
  • FBIO 08-14-2025
  • LPSN 11-06-2025
  • Dividend Yield
  • FBIO N/A
  • LPSN N/A
  • EPS Growth
  • FBIO N/A
  • LPSN N/A
  • EPS
  • FBIO N/A
  • LPSN N/A
  • Revenue
  • FBIO $59,301,000.00
  • LPSN $271,750,000.00
  • Revenue This Year
  • FBIO $51.59
  • LPSN N/A
  • Revenue Next Year
  • FBIO $44.74
  • LPSN N/A
  • P/E Ratio
  • FBIO N/A
  • LPSN N/A
  • Revenue Growth
  • FBIO N/A
  • LPSN N/A
  • 52 Week Low
  • FBIO $1.33
  • LPSN $0.61
  • 52 Week High
  • FBIO $3.90
  • LPSN $2.08
  • Technical
  • Relative Strength Index (RSI)
  • FBIO 71.65
  • LPSN 47.03
  • Support Level
  • FBIO $2.79
  • LPSN $0.88
  • Resistance Level
  • FBIO $3.90
  • LPSN $0.93
  • Average True Range (ATR)
  • FBIO 0.25
  • LPSN 0.06
  • MACD
  • FBIO 0.12
  • LPSN -0.01
  • Stochastic Oscillator
  • FBIO 73.04
  • LPSN 40.42

About FBIO Fortress Biotech Inc.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.

About LPSN LivePerson Inc.

LivePerson Inc is the enterprise leader in digital customer conversation. The Conversational Cloud, the Company's enterprise-class digital customer conversation platform, is trusted by the world's top brands to accelerate their contact center transformation, orchestrate conversations across all channels, departments, and systems, increase agent productivity, and deliver more personalized, AI-empowered customer experiences. The company has a presence in the United Kingdom, Asia-Pacific, Latin America, and Europe.

Share on Social Networks: